| Descriptor English: | 2-Acetylaminofluorene | ||||||
| Descriptor Spanish: |
2-Acetilaminofluoreno
| ||||||
| Descriptor Portuguese: | 2-Acetilaminofluoreno | ||||||
| Descriptor French: | N-Fluorén-2-yl-acétamide | ||||||
| Entry term(s): |
2 Acetamidofluorene 2 Acetylaminofluorene 2 Fluorenylacetamide 2-AAF 2-Acetamidofluorene 2-Fluorenylacetamide AAF, Aminofluorene Acetylaminofluorene Aminofluorene AAF Fluoren 2 ylacetamide Fluoren-2-ylacetamide N 2 Fluorenylacetamide N Acetyl 2 Aminofluorene N-2-Fluorenylacetamide N-Acetyl-2-Aminofluorene |
||||||
| Tree number(s): |
D02.065.064.150 D02.241.081.018.110.080 D02.455.426.559.847.389.050 D04.615.389.050 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D015073 | ||||||
| Scope note: | A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines. |
||||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Pharm Action: |
Carcinogens |
||||||
| Registry Number: | 9M98QLJ2DL | ||||||
| CAS Type 1 Name: | Acetamide, N-9H-fluoren-2-yl- | ||||||
| Previous Indexing: |
Acetamides (1971-1974) Fluorenes (1966-1974) |
||||||
| Public MeSH Note: | 83; was ACETYLAMINOFLUORENE 1980-82; was ACETYLAMINOFLUORENE see under FLUORENES 1975-79 |
||||||
| Online Note: | use 2-ACETYLAMINOFLUORENE to search ACETYLAMINOFLUORENE 1975-82 |
||||||
| History Note: | 83; was ACETYLAMINOFLUORENE 1980-82; was ACETYLAMINOFLUORENE see under FLUORENES 1975-79 |
||||||
| DeCS ID: | 115 | ||||||
| Unique ID: | D015073 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1980/01/01 | ||||||
| Date of Entry: | 1974/11/11 | ||||||
| Revision Date: | 2013/07/08 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds
|
|
2-Acetylaminofluorene
- Preferred
Acetylaminofluorene
- Broader
| Concept UI |
M0023186 |
| Scope note | A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines. |
| Preferred term | 2-Acetylaminofluorene |
| Entry term(s) |
2 Acetamidofluorene 2 Acetylaminofluorene 2 Fluorenylacetamide 2-AAF 2-Acetamidofluorene 2-Fluorenylacetamide AAF, Aminofluorene Aminofluorene AAF Fluoren 2 ylacetamide Fluoren-2-ylacetamide N 2 Fluorenylacetamide N Acetyl 2 Aminofluorene N-2-Fluorenylacetamide N-Acetyl-2-Aminofluorene |
| Concept UI |
M0023187 |
| Preferred term | Acetylaminofluorene |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey